Cancer Analysis

Related Publications

Scollon S, Bergstrom K, Kerstein RA, Wang T, Hilsenbeck SG, Ramamurthy U, et al.. Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients. Genome Med. 2014 ;6(9):69.

Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, et al.. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet. 2014 ;46(12):1267-73.

Xia Z, Donehower LA, Cooper TA, Neilson JR, Wheeler DA, Wagner EJ, et al.. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. Nat Commun. 2014 ;5:5274.

Yang JY, Dunker A, Liu JS, Qin X, Arabnia HR, Yang W, et al.. Advances in translational bioinformatics facilitate revealing the landscape of complex disease mechanisms. BMC Bioinformatics. 2014 ;15 Suppl 17(Suppl 17):I1.

Yang W, Yoshigoe K, Qin X, Liu JS, Yang JY, Niemierko A, et al.. Identification of genes and pathways involved in kidney renal clear cell carcinoma. BMC Bioinformatics. 2014 ;15 Suppl 17(Suppl 17):S2.

Takahashi Y, Pickering CR, Gelbard A, Drummond JA, Wheeler DA, Kupferman ME, et al.. Genomic Characterization of Sinonasal Undifferentiated Carcinoma. J Neurol Surg B. 2014 ;75:A084.

Boone PM, Soens ZT, Campbell IM, Stankiewicz P, Cheung SWai, Patel A, et al.. Incidental copy-number variants identified by routine genome testing in a clinical population. Genet Med. 2013 ;15(1):45-54.

Donehower LA, Creighton CJ, Schultz N, Shinbrot E, Chang K, Gunaratne PH, et al.. MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes. J Pathol. 2013 ;229(1):99-110.

Niu T, Smith DL, Yang Z, Gao S, Yin T, Jiang Z-H, et al.. Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing. Pharm Res. 2013 ;30(3):836-46.

Powell BC, Jiang L, Muzny DM, Treviño LR, Dreyer ZE, Strong LC, et al.. Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing. Pediatr Blood Cancer. 2013 ;60(6):E1-3.